Jetzt noch länger handeln: 7:30-23:00 Uhr Samstag: 14-19 UhrJetzt noch länger handeln: 7:30-23:00 Uhr Samstag: 14-19 Uhr (mit ausgewählten Partnern) Mit uns direkt oder auf gettex. Über Deinen Broker oder Deine Bank.

COGSTATE

WKNA0ESLQ
SektorGesundheit
Index-
1,48-0,00
- 0,14%
28.04.2026 11:14
1,48-0,00
- 0,14%
28.04.2026 11:14
Verkaufen
1,452VerkaufenStück: 1.500
Kaufen
1,512KaufenStück: 1.500
Eröffnung
1,466
Hoch
1,48
Tief
1,466
Marktkapitalisierung in Mio. (AUD)
417,225
Volatilität (30 Tage)
-
P/E Ratio
28,271
Dividende pro Aktie
0,0185
Gewinn pro Aktie
0,0863
Über COGSTATE LTD
Firmensitz
Level 32, 367 Collins Street
3000, MELBOURNE
AU
Mitarbeitende
-
Streubesitz
54,66 %

Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.

Mehr zum Thema
    Related Events
    • Full Year 2026 CogState Ltd Earnings Release

      19.08.2026

      23:00

      Veröffentlichungen von Geschäftszahlen

    • CogState Ltd Annual Shareholders Meeting

      16.10.2026

      00:00

      Jährliche Aktionärs-Meetings

    Detaillierte Ansicht